查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2081952

血糖值監測設備市場：2026-2032年全球市場預測（依產品類型、技術、應用、最終用戶及通路分類）

Glucose Monitoring Devices Market by Product Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血糖值監測設備市場規模將達到 217.4 億美元，複合年成長率為 12.81%。

主要市場統計數據
基準年 2025 93.4億美元
預計年份：2026年 103.6億美元
預測年份 2032 217.4億美元
複合年成長率 (%) 12.81%

血糖監測設備正逐漸成為糖尿病管理的核心基礎設施，從間歇性的指尖採血檢測轉向連網、連續且具有臨床應用價值的血糖數據。公共衛生需求已得到充分證實。根據世界衛生組織（WHO）估計，2022年全球約有8.3億人患有糖尿病。

該市場涵蓋血糖儀、試紙、持續血糖監測（CGM）系統、瞬感血糖監測感測器、整合式CGM平台、穿戴式式發送器、行動應用程式和遠端患者監護工作流程。市場成長的促進因素包括人口老化、第二型糖尿病盛行率上升、胰島素使用量增加、保險覆蓋範圍擴大，以及目標攝取時間（TIR）指標在減少血糖波動和改善糖尿病治療決策方面所展現的臨床價值。

血糖監測領域的變革性變化

血糖監測設備領域正從被動監測轉向持續性和預防性的糖尿病管理。持續血糖監測（CGM）正日益被納入治療指南，美國糖尿病協會（ADA）建議許多接受胰島素治療的第一型糖尿病和第2型糖尿病患者使用CGM。在美國，醫療保險和醫療補助服務中心（CMS）於2023年擴大了CGM的覆蓋範圍，透過納入更多胰島素使用者和某些存在嚴重低血糖問題的患者，促進了CGM從小眾技術向標準治療的轉變。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過將連續的感測器讀數轉化為可預測的個人化見解，進一步提升了血糖監測設備的價值，這些見解可立即應用於工作流程。 AI 驅動的分析可以支援血糖值趨勢預測、低血糖和高血糖風險警報、飲食和活動模式識別、感測器品質檢查、人群風險分層以及遠端監測計畫中的臨床醫生優先排序。隨著連續血糖監測 (CGM) 的普及，可用於醫療決策的真實世界血糖數據量不斷增加，這些功能顯得特別重要。

對關鍵區域的洞察

亞太地區是重點關注區域，因為中國和印度擁有全球規模最大的糖尿病患者群體之一。同時，日本、澳洲和韓國正透過專業的醫療保健、數位化醫療基礎設施、糖尿病教育網路和保險報銷體系，在推廣應用先進的動態血糖監測（CGM）方面取得更大進展。北美地區憑藉FDA批准的技術、透過CMS擴大的保險覆蓋範圍、強大的內分泌網路、便捷的藥房以及對「血糖達標時間」（Time-in-Rage）管理的高度重視，繼續保持著創新和應用中心的地位。

對關鍵群體的洞察

東協地區的需求受多種因素影響，包括第2型糖尿病盛行率上升、都市區醫療保健服務覆蓋範圍擴大、藥房網路不斷成長以及保險報銷體系差異，因此，價格可負擔性、教育普及以及與分銷商建立合作關係至關重要。海灣合作理事會（GCC）全國糖尿病盛行率高，且醫療保健系統資金充足，這推動了持續血糖監測（CGM）、數位化糖尿病診所、預防性篩檢和互聯醫療計畫的普及。歐盟的需求則受到醫療設備法規（MDR）、資料保護法規、醫療技術評估、國家保險報銷決策以及跨境數位健康優先事項的影響。

主要國家的概況

美國在持續血糖監測（CGM）創新方面處於主導地位，不斷擴大保險覆蓋範圍、遠端患者監護和互聯糖尿病平台；加拿大則受益於各省的保險覆蓋政策和第1型糖尿病的高臨床應用率。墨西哥和巴西的需求成長主要受糖尿病盛行率、私人醫療保健的擴張、公共衛生計畫以及對價格合理的監測工具的需求所驅動。在歐洲，英國的發展受英國國家醫療服務體系（NHS）指南和英國國家衛生與臨床最佳化研究所（NICE）建議的影響；德國的發展受法定保險覆蓋途徑和數位醫療應用的影響；法國的發展受集中式保險報銷評估的影響；義大利和西班牙的發展受影響區域醫療保健系統採購的影響；俄羅斯的發展則受區域採購和供應鏈因素的影響。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗血糖監測（CGM）和血糖監測產品線，以滿足高階和經濟型市場的需求。與胰島素幫浦、電子健康記錄、行動應用程式、藥房工作流程和遠端患者監護平台的互通性不應被視為可選項，而應被視為競爭優勢的必要條件。

調查方法

本研究的調查方法是基於二手資料研究和三角驗證，利用了世界衛生組織（WHO）、國際糖尿病聯盟（IDF）、美國疾病控制與預防中心（CDC）、美國食品藥物管理局（FDA）、醫療保險和醫療補助服務中心（CMS）、美國糖尿病協會（ADA）、英國國家衛生與臨床最佳化研究所（NICE）、經濟合作與金融組織（資訊來源）、金融組織的金融檢驗（NICE）

結論

隨著醫療保健系統向持續數據收集、早期療育和數位整合的慢性病管理轉型，血糖監測設備將在未來的糖尿病護理中發揮核心作用。隨著糖尿病盛行率的上升、持續血糖監測（CGM）醫保覆蓋範圍的擴大、人工智慧分析、遠端監測以及互通性標準的製定，監測技術在臨床和家庭環境中都變得日益重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章血糖值監測設備市場：依產品類型分類

  • 自我血糖監測（SMBG）設備
    • 血糖值儀
    • 測試條
    • 《採血針》
  • 連續血糖監測（CGM）系統
    • 即時動態血糖監測
    • 間歇掃描式動態血糖監測
    • 感應器
  • 專業/臨床即時檢測設備
  • 非侵入性血糖監測設備

第8章血糖值監測設備市場：依技術分類

  • 侵襲型
    • 比色法
    • 電化學安培法
  • 微創
  • 非侵入性
    • 光學光譜學
    • 經皮取

第9章：血糖值監測設備市場：依應用分類

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

第10章：血糖值監測設備市場：依最終用戶分類

  • 門診治療
  • 居家照護
  • 醫院
    • 私立醫院
    • 公立醫院

第11章血糖值監測設備市場：依通路分類

  • 網路商店
    • 每家公司的網站
    • 電子商務平台
  • 離線

第12章血糖值監測設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章血糖值監測設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章血糖值監測設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Beta Bionics, Inc.
  • Beurer GmbH
  • Bionime Corporation
  • Dexcom, Inc.
  • DiaMonTech AG
  • F. Hoffmann-La Roche Ltd
  • ForaCare, Inc.
  • GlySens Incorporated
  • i-SENS, Inc.
  • Insulet Corporation
  • LifeScan IP Holdings, LLC
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nemaura Medical Inc.
  • Nipro Corporation
  • Nova Biomedical Corporation
  • Novo Nordisk A/S
  • Omron Healthcare Co., Ltd.
  • Prodigy Diabetes Care, LLC
  • Rossmax International Ltd.
  • Sanofi SA
  • Senseonics Holdings, Inc.
  • Sinocare Inc.
  • TaiDoc Technology Corporation
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • WaveForm Technologies, Inc.
  • Ypsomed Holding AG
Product Code: MRR-436B79517C57

The Glucose Monitoring Devices Market is projected to grow by USD 21.74 billion at a CAGR of 12.81% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.34 billion
Estimated Year [2026] USD 10.36 billion
Forecast Year [2032] USD 21.74 billion
CAGR (%) 12.81%

Glucose monitoring devices are becoming core infrastructure for diabetes management, moving beyond episodic finger-stick testing toward connected, continuous, and clinically actionable glucose data. The public health need is well documented: the World Health Organization estimates that diabetes affected about 830 million people globally in 2022.

The market includes self-monitoring blood glucose meters, test strips, continuous glucose monitoring systems, flash glucose monitoring sensors, integrated CGM platforms, wearable transmitters, mobile applications, and remote patient monitoring workflows. Growth is supported by aging populations, rising type 2 diabetes prevalence, expanded insulin use, broader reimbursement, and the proven clinical value of time-in-range metrics for reducing glycemic variability and improving diabetes care decisions.

Transformative Shifts in the Glucose Monitoring Landscape

The glucose monitoring devices landscape is shifting from reactive measurement to continuous, preventive diabetes care. Continuous glucose monitoring is increasingly embedded in treatment guidelines, with the American Diabetes Association supporting CGM use across many people with type 1 diabetes and insulin-treated type 2 diabetes. In the United States, the Centers for Medicare & Medicaid Services expanded CGM coverage in 2023 to include more insulin users and selected people with problematic hypoglycemia, reinforcing the move from niche technology to standard care.

Regulatory and technology changes are also transforming competition. The U.S. FDA created the integrated continuous glucose monitoring pathway to support interoperable sensors, while Europe's Medical Device Regulation has raised evidence and post-market surveillance expectations. At the same time, smartphone connectivity, cloud analytics, smaller sensors, longer wear times, pharmacy distribution, and remote patient monitoring are improving access, adherence, and patient engagement.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of glucose monitoring devices by converting continuous sensor readings into predictive, personalized, and workflow-ready insights. AI-enabled analytics can support glucose trend forecasting, hypoglycemia and hyperglycemia risk alerts, meal and activity pattern recognition, sensor quality checks, population-level risk stratification, and clinician prioritization in remote monitoring programs. These capabilities are especially relevant as CGM adoption increases the volume of real-world glucose data available for care decisions.

The cumulative impact is a transition from device-centric monitoring to decision-support ecosystems. In automated insulin delivery, glucose sensors already work with control algorithms and insulin pumps to adjust insulin delivery within regulated systems. Industry leaders must pair AI innovation with clinical validation, explainability, cybersecurity, bias testing, human factors evidence, and compliance with software-as-a-medical-device expectations from regulators such as the FDA and European authorities.

Key Regional Insights

Asia-Pacific is a high-priority region because China and India account for some of the world's largest diabetes populations, while Japan, Australia, and South Korea show stronger adoption of advanced CGM through specialist care, digital health infrastructure, diabetes education networks, and reimbursement pathways. North America remains a leading innovation and adoption hub, supported by FDA-cleared technologies, CMS coverage expansion, strong endocrinology networks, pharmacy access, and high awareness of time-in-range management.

Latin America is advancing through private healthcare channels and public-sector diabetes initiatives, with Brazil and Mexico serving as major demand centers for both blood glucose meters and continuous glucose monitoring. Europe benefits from structured diabetes care, CE-marked innovation, national reimbursement decisions, and guideline-driven adoption, although country-level access varies due to health technology assessment and regional purchasing models. The Middle East faces a high diabetes burden, particularly in Gulf economies, creating demand for premium monitoring, digital diabetes clinics, and remote care models. Africa remains access-constrained, with opportunities centered on affordable blood glucose meters, reliable test-strip supply, clinician training, patient education, and scalable mobile health support.

Key Group Insights

ASEAN demand is shaped by rising type 2 diabetes prevalence, expanding urban healthcare access, growing pharmacy networks, and uneven reimbursement, making affordability, education, and distributor partnerships critical. The GCC has high diabetes prevalence and well-funded health systems, supporting adoption of CGM, digital diabetes clinics, preventive screening, and connected care programs. The European Union is influenced by MDR compliance, data protection rules, health technology assessment, national reimbursement decisions, and cross-border digital health priorities.

BRICS markets combine scale with complexity: China and India offer large patient pools and local manufacturing momentum, Brazil expands access through mixed public-private channels, Russia faces procurement and supply constraints, and South Africa anchors demand in sub-Saharan Africa. G7 countries represent advanced reimbursement, regulatory maturity, clinical evidence generation, and early adoption of integrated diabetes technologies. NATO is not a diabetes policy bloc, but its member countries influence cybersecurity expectations, medical supply resilience, procurement discipline, and digital infrastructure standards relevant to connected glucose monitoring devices.

Key Country Insights

The United States leads in CGM innovation, reimbursement expansion, remote patient monitoring, and connected diabetes platforms, while Canada benefits from provincial coverage decisions and strong clinical adoption in type 1 diabetes. Mexico and Brazil show growing demand driven by diabetes prevalence, private care expansion, public health programs, and the need for affordable monitoring. In Europe, the United Kingdom is shaped by NHS guidance and NICE recommendations, Germany by statutory insurance pathways and digital health adoption, France by centralized reimbursement evaluation, Italy and Spain by regional health system purchasing, and Russia by localized procurement and supply-chain considerations.

In Asia-Pacific, China combines a very large diabetes population with domestic medtech manufacturing, hospital-led adoption, and expanding digital health infrastructure, while India requires cost-sensitive devices, broad distribution, clinician training, and education-led engagement to improve routine glucose testing. Japan is characterized by advanced healthcare infrastructure and aging-related diabetes needs, Australia by structured reimbursement and strong diabetes education networks, and South Korea by technology readiness, hospital integration, smartphone penetration, and digital health adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated CGM and blood glucose monitoring portfolios that address both premium and affordability segments. Interoperability with insulin pumps, electronic health records, mobile applications, pharmacy workflows, and remote patient monitoring platforms should be treated as a competitive requirement rather than an optional feature.

Companies should invest in AI governance, cybersecurity, post-market evidence, human factors testing, and real-world outcomes that demonstrate improved time in range, fewer hypoglycemic events, better adherence, and improved care-team efficiency. Market access strategies must be localized by reimbursement status, diabetes burden, pharmacy reach, clinician training needs, and digital infrastructure maturity, while supply-chain resilience for sensors, semiconductors, enzymes, adhesives, batteries, and test strips remains essential.

Research Methodology

Research methodology is based on secondary research and triangulation from authoritative public sources, including the World Health Organization, International Diabetes Federation, U.S. Centers for Disease Control and Prevention, U.S. Food and Drug Administration, Centers for Medicare & Medicaid Services, American Diabetes Association, NICE, OECD, World Bank health indicators, peer-reviewed clinical literature, and national diabetes or reimbursement bodies.

The methodology emphasizes verified epidemiology, regulatory developments, reimbursement policies, clinical guideline direction, technology adoption signals, and digital health readiness across regions and countries. Insights were synthesized using market-structure analysis, demand-driver assessment, technology trend evaluation, policy review, and geographic comparison to support leader-relevant and decision-ready content on glucose monitoring devices.

Conclusion

Glucose monitoring devices are central to the future of diabetes care as health systems shift toward continuous data, earlier intervention, and digitally connected chronic disease management. Rising diabetes prevalence, expanded CGM reimbursement, AI-enabled analytics, remote monitoring, and interoperability standards are strengthening the role of monitoring technologies in both clinical and home settings.

The strongest opportunities will belong to organizations that combine accurate sensors, affordable access, regulatory discipline, secure data ecosystems, reliable supply chains, and evidence-based outcomes. As adoption widens across developed and emerging markets, glucose monitoring devices will remain a foundational category in precision diabetes management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Glucose Monitoring Devices Market, by Product Type

  • 7.1. Self-Monitoring Blood Glucose (SMBG) Devices
    • 7.1.1. Blood Glucose Meters
    • 7.1.2. Test Strips
    • 7.1.3. Lancets
  • 7.2. Continuous Glucose Monitoring (CGM) Systems
    • 7.2.1. Real-Time CGM
    • 7.2.2. Intermittently Scanned CGM
    • 7.2.3. Sensors
  • 7.3. Professional / Clinical Point-of-Care Devices
  • 7.4. Non-Invasive Glucose Monitoring Devices

8. Glucose Monitoring Devices Market, by Technology

  • 8.1. Invasive
    • 8.1.1. Colorimetric
    • 8.1.2. Electrochemical Amperometric
  • 8.2. Minimally Invasive
  • 8.3. Non Invasive
    • 8.3.1. Optical Spectroscopy
    • 8.3.2. Transdermal Extraction

9. Glucose Monitoring Devices Market, by Application

  • 9.1. Gestational Diabetes
  • 9.2. Type 1 Diabetes
  • 9.3. Type 2 Diabetes

10. Glucose Monitoring Devices Market, by End User

  • 10.1. Ambulatory Care
  • 10.2. Home Care
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals

11. Glucose Monitoring Devices Market, by Distribution Channel

  • 11.1. Online Stores
    • 11.1.1. Company Websites
    • 11.1.2. E Commerce Platforms
  • 11.2. Offline

12. Glucose Monitoring Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Glucose Monitoring Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Glucose Monitoring Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. ACON Laboratories, Inc.
  • 16.3. AgaMatrix, Inc.
  • 16.4. ARKRAY, Inc.
  • 16.5. Ascensia Diabetes Care Holdings AG
  • 16.6. B. Braun Melsungen AG
  • 16.7. Beta Bionics, Inc.
  • 16.8. Beurer GmbH
  • 16.9. Bionime Corporation
  • 16.10. Dexcom, Inc.
  • 16.11. DiaMonTech AG
  • 16.12. F. Hoffmann-La Roche Ltd
  • 16.13. ForaCare, Inc.
  • 16.14. GlySens Incorporated
  • 16.15. i-SENS, Inc.
  • 16.16. Insulet Corporation
  • 16.17. LifeScan IP Holdings, LLC
  • 16.18. Medtronic plc
  • 16.19. MicroPort Scientific Corporation
  • 16.20. Nemaura Medical Inc.
  • 16.21. Nipro Corporation
  • 16.22. Nova Biomedical Corporation
  • 16.23. Novo Nordisk A/S
  • 16.24. Omron Healthcare Co., Ltd.
  • 16.25. Prodigy Diabetes Care, LLC
  • 16.26. Rossmax International Ltd.
  • 16.27. Sanofi S.A.
  • 16.28. Senseonics Holdings, Inc.
  • 16.29. Sinocare Inc.
  • 16.30. TaiDoc Technology Corporation
  • 16.31. Tandem Diabetes Care, Inc.
  • 16.32. Terumo Corporation
  • 16.33. Trividia Health, Inc.
  • 16.34. WaveForm Technologies, Inc.
  • 16.35. Ypsomed Holding AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL GLUCOSE MONITORING DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL GLUCOSE MONITORING DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL GLUCOSE MONITORING DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL GLUCOSE MONITORING DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL GLUCOSE MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TEST STRIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TEST STRIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LANCETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LANCETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL REAL-TIME CGM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL REAL-TIME CGM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL REAL-TIME CGM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SENSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SENSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SENSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PROFESSIONAL / CLINICAL POINT-OF-CARE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PROFESSIONAL / CLINICAL POINT-OF-CARE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PROFESSIONAL / CLINICAL POINT-OF-CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-INVASIVE GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLORIMETRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COLORIMETRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COLORIMETRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ELECTROCHEMICAL AMPEROMETRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ELECTROCHEMICAL AMPEROMETRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ELECTROCHEMICAL AMPEROMETRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NON INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NON INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OPTICAL SPECTROSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OPTICAL SPECTROSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OPTICAL SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TRANSDERMAL EXTRACTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TRANSDERMAL EXTRACTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TRANSDERMAL EXTRACTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AMBULATORY CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AMBULATORY CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AMBULATORY CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ONLINE STORES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ONLINE STORES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ONLINE STORES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL COMPANY WEBSITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL COMPANY WEBSITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL COMPANY WEBSITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL E COMMERCE PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL E COMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL E COMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 180. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 184. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 190. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GCC GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 216. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 220. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 222. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 226. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. G7 GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 228. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 235. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. NATO GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 253. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 256. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 257. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 259. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 260. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 263. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. CANADA GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 265. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 268. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 269. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 271. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 272. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 275. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. MEXICO GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 277. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 280. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 281. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 283. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 284. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 287. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. BRAZIL GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED KINGDOM GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 301. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 304. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 305. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 306. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 307. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 308. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 311. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. GERMANY GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 313. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 316. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 317. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 318. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 319. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 320. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 323. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 324. FRANCE GLUCOSE MONITORING DEVICES MARKET SIZE, BY ONLINE STORES, 2018-2032 (USD MILLION)
  • TABLE 325. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY SELF-MONITORING BLOOD GLUCOSE (SMBG) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 328. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 329. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 330. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 331. RUSSIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY NON INVASIVE, 2018-2032 (USD MILLION)

TABLE